HEALTH AIIMS Delhi to screen children in 12-18 age group for Covaxin trials In a latest development, as per sources, the All India Institute of Medical Sciences (AIIMS) in Delhi from Monday (June 7) will start screening for the clinical trials of the homegrown anti-Covid vaccine, Covaxin, on children, says a report.
/dnp-english/media/agency_attachments/2024/11/25/2024-11-25t064936166z-dnp-india-logo-640x480-dnp-news-2.png){kind=logo}